Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TC-110 T-cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
TC-110 T-cells consist of T-lymphocytes engineered to express a CD19-targeting T cell receptor linked to a binder domain, which potentially induces a T-cell response against tumor cells with reduced inflammation (Cancer Res 2019;79(13 Suppl):Abstract nr 2330). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C172366 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TC-110 T-cells | TC-110 T-cells | 0 | 1 |